USA – FDA issues guidance on developing long-acting local anesthetics

The US Food and Drug Administration (FDA) has issued draft guidance on the development of local anesthetic products with a prolonged duration of effect...

USA – Pharma wants FDA’s IND reporting rule better aligned with ICH E2F

Pharmaceutical industry stakeholders urged the US Food and Drug Administration (FDA) to better align its investigational new drug application (IND) annual reporting proposal with...

USA – FDA revises guidance on electronic systems and signatures in clinical trials

The US Food and Drug Administration (FDA) on Wednesday revised its draft guidance on electronic systems, records and signatures in clinical trials. While the...

USA – Advanced manufacturing: GAO, USP reports say regulatory enhancements needed

The Government Accountability Office (GAO) and the United States Pharmacopeia (USP) asserted in two recent reports that the regulators need to address some of...
Topical Drug Products for Cutaneous Application: Human Safety Assessment Guidance

USA – FDA warns pharmacy benefit company for distributing unapproved foreign drugs

The US Food and Drug Administration (FDA) recently warned pharmacy benefit firm ElectRx for substituting prescription drugs ordered by its customers with drugs sourced...

USA – FDA approves first treatment for Rett Syndrome

FDA has approved Daybue (trofinetide) oral solution as the first treatment for Rett syndrome, a rare, genetic neurological disorder. Daybue is approved for the...

USA – Pfizer: le spray nasal anti-migraine approuvé par la FDA

Pfizer a annoncé vendredi que la Food and Drug Administration (FDA) américaine avait approuvé le Zavzpret, son spray nasal pour le traitement de la...

USA – Generic drugmakers seek clarity on pre-submission facility correspondence

Drugmakers want clarifications on an updated draft guidance the US Food and Drug Administration (FDA) recently released on pre-submission facility correspondence (PFC) for generic...
New guidance on biologics affects authorized generics

USA – FDA seeks feedback on artificial intelligence in drug manufacturing

The US Food and Drug Administration (FDA) is soliciting feedback on how to incorporate artificial intelligence (AI) and advanced manufacturing techniques into the current...

USA – FDA issues guidance on drug development for neovascular age-related AMD

The US Food and Drug Administration (FDA) has issued draft guidance for industry on the development of drugs to treat neovascular or “wet” age-related...

NOS PROCHAINES FORMATIONS